Dolby Laboratories (NYSE:DLB) SVP Shriram Revankar Sells 3,000 Shares of Stock

Dolby Laboratories (NYSE:DLB) SVP Shriram Revankar sold 3,000 shares of Dolby Laboratories stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $62.71, for a total value of $188,130.00. Following the completion of the transaction, the senior vice president directly owned 73,274 shares in the company, valued at approximately $4,595,012.54. This represents a 3.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Dolby Laboratories Stock Performance

NYSE:DLB opened at $61.22 on Wednesday. Dolby Laboratories has a fifty-two week low of $48.26 and a fifty-two week high of $75.66. The company has a 50 day simple moving average of $53.81 and a two-hundred day simple moving average of $58.46. The company has a market capitalization of $5.73 billion, a PE ratio of 26.05 and a beta of 0.80.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The firm had revenue of $305.00 million for the quarter, compared to the consensus estimate of $311.96 million. During the same quarter in the previous year, the company earned $0.78 EPS. The company’s revenue for the quarter was down 3.3% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. Research analysts predict that Dolby Laboratories will post 3.26 EPS for the current year.

Dolby Laboratories announced that its Board of Directors has authorized a share buyback program on Thursday, July 30th that allows the company to buyback $350.00 million in shares. This buyback authorization allows the electronics maker to purchase up to 7% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s management believes its stock is undervalued.

Dolby Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 19th. Shareholders of record on Tuesday, August 11th will be given a dividend of $0.36 per share. The ex-dividend date of this dividend is Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a yield of 2.4%. Dolby Laboratories’s dividend payout ratio is 61.28%.

Hedge Funds Weigh In On Dolby Laboratories

Institutional investors have recently made changes to their positions in the stock. Fifth Third Bancorp increased its position in Dolby Laboratories by 34.7% in the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after buying an additional 192 shares in the last quarter. Aquatic Capital Management LLC bought a new position in Dolby Laboratories in the third quarter worth approximately $56,000. iSAM Funds UK Ltd bought a new position in Dolby Laboratories in the third quarter worth approximately $68,000. Quarry LP grew its stake in Dolby Laboratories by 1,486.7% in the fourth quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock valued at $76,000 after acquiring an additional 1,115 shares during the period. Finally, Farther Finance Advisors LLC increased its holdings in shares of Dolby Laboratories by 48.4% during the fourth quarter. Farther Finance Advisors LLC now owns 1,232 shares of the electronics maker’s stock valued at $79,000 after acquiring an additional 402 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on DLB shares. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Barrington Research reaffirmed an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research note on Monday, June 15th. Weiss Ratings downgraded Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, August 13th. Finally, Rosenblatt Securities restated a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a report on Friday, July 31st. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $83.00.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.